The Global Lice Treatment Market is expected to grow at an approximate CAGR of 6.5% during forecast period, 2018–2023.Lice are parasites striving on human blood. They can be found on head or pubic areas. From the past few years, rising prevalence of head lice provided developmental backgrounds for the market. Factors such as growing children population and increasing disposable income are driving the market. However, lack of awareness followed by low per capita healthcare expenditure in the developing and low-income countries is estimated to restraint the market growth, during the forecast period.
Lice are parasites that feed on human blood. They are majorly found on the head and near the pubic areas. However, in certain cases, infestations of head lice are reported to occur by close contact with infected people or through pets. From the past few years, the prevalence of head lice has increased, resulting in a parallel demand for therapeutics. Lice Treatment market grows at 6.5% of CAGR which is segmented based on type, treatment, end user, and region.
An article published by the Centers for Disease Control and Prevention in 2015, stated that ~6 million to 12 million infestations occur each year within the U.S. Moreover, the article suggested that most of the reported cases were for children of 3 to 11 years of age. Since, this susceptible population is increasing within the U.S., the market is projected to grow within the region.
According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. However, factors such as lack of awareness and low per capita healthcare expenditure in the developing and low-income countries is estimated to be major restriction for market growth during the forecast period, 2018-2023
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/6934
Lice Treatment Market – Key Players
Some of the key players in the Global Lice Treatment Market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others
Lice Treatment Market – Segmentation
The Global Lice Treatment Market is segmented based on type, treatment, end user, and region
On the basis of type, the market is segmented into pediculosis capitis, pediculosis corporis, pediculosis pubis. Based on treatment, the market is devised into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is sub-segmented into permethrin, pyrethrin, others.
The prescription segment is sub-segmented into ivermectin, Spinosad, malathion, and others. By end user, the market is divided into hospitals & clinics, retail pharmacies, online platform. In the current scope of the study the above-mentioned segments are divided into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.
Lice Treatment Market – Regional Analysis
The Americas leads the Global Lice Treatment Market. This can be attributed due to growing child population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth. In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global lice treatment market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.
Browse Complete 90 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/lice-treatment-market-6934
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312